3 assets in Early T Cell Progenitor Acute Lymphoblastic Leukemia

Therapeutic assets addressing Early T Cell Progenitor Acute Lymphoblastic Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cytarabine Early T Cell Progenitor Acute Lymphoblastic Leukemia	yuejun Liu	P2/3	BB (64)
Azacitidine Early T Cell Progenitor Acute Lymphoblastic Leukemia	yuejun Liu	P2	CCC (53)
Venetoclax Early T Cell Progenitor Acute Lymphoblastic Leukemia	yuejun Liu	P2	CCC (53)